program was part of IDPH's activities for the Million Hearts initiative.
Objectives 1) Conduct team building activities for provider-community pharmacist teams in small communities. 2) Determine the impact of the team approach on practitioner-reported consequences.
3) Identify obstacles to the team approach and ways to overcome them.
Team Recruitment
The goal was to recruit twelve medical clinic-community pharmacy pairs. Potential practice pairs were linked at the community level. Letters were sent to pharmacies and physicians for team recruitment. The pharmacies were on a list of 72 practice sites that provide practice experiences to University of Iowa pharmacy students, and provide advanced levels of pharmacy services. The initial physicians contacted were 33 members in the Iowa Research Network (IRENE), a practice-based research network in Iowa, and were working in micropolitan or rural areas.
Practitioners who returned a fax were called to provide further information. Once a site stated its willingness to participate, it helped identify sites to form a providerpharmacist team. These prospective sites were contacted about participating using mailings, faxes, and telephone, depending on their preference. After a provider/clinic and a pharmacist/pharmacy were recruited for a team, a team building session was scheduled.
Team Building
Each team held a face-to-face 60-minute team building session, during which the project leaders facilitated a discussion to clarify team member views of team management of hypertension, identify specific roles for team members, discuss how to target patients, and develop communication procedures to exchange information. The teams completed and shared a worksheet describing their decisions for these topics. Some of the team building sessions included one provider and one pharmacist, while other sessions included multiple providers and/or pharmacists.
A toolkit on team management of BP was used to support the provider-pharmacist teams. Both a printed version and an electronic version (e.g., PDF files) of the toolkit were given to the practitioners. Topics in the toolkit included: project leader contact information, description of the team model of BP management, evidence supporting the team approach, goals for the project, references to the current BP management guidelines (JNC7), detailed suggestions for management, sample interventions to address uncontrolled BP, and instructions for proper measurement of BP. In addition, numerous one-page patient education materials (e.g., diet and home BP monitoring) were included.
Team Management
Each provider-pharmacist team tailored the team management of BP model to fit their practices. For example, one team had the pharmacist fax summaries of BP visits, while another had the pharmacist call on the telephone. This tailoring began at the team building session, and continued throughout the team management process. The model for team management of BP contained the following activities: patient identification/recruitment, BP visits, and team member communication.
Providers and pharmacists identified patients with newly diagnosed or uncontrolled hypertension. Some pharmacies ran a report, identifying patients with a BP medication prescribed by the participating provider(s), which was sent to the clinic to verify that provider(s) had seen them recently. Once confirmed, they had a registry of "shared BP patients," which helped focus of team management of BP activities. Other teams simply had the provider and pharmacist identify patients at clinic or pharmacy visits respectively.
Patients who participated in team management typically met with the pharmacist for a baseline assessment including BP measurement and discussion of anti-hypertensive medications. If the patient was not at goal, the pharmacist could ask about medication adherence and lifestyle issues. If it appeared the therapy was being taken as directed but not achieving the BP goal, the pharmacist would communicate with the provider or recommend the patient visit the provider. Some pharmacists recommended specific drug changes, while others relied solely on the provider to determine drug therapy adjustments.
Pharmacists scheduled follow-up visits with patients as needed. The practitioners determined the need for follow-up visits for each patient during the team management period. The pharmacists logged the BP visits to track the extent of team management of BP and for the program evaluation.
rural towns and micropolitan areas in Iowa with several types of providers.
Methods
Given the time spent recruiting and conducting team building sessions, some teams had 5 months for the team management period, while others had 3 months. Providers and pharmacists were asked to complete two surveys about team management: one baseline and one follow-up. The surveys asked about team member relations, how the team BP management occurred, the presence of any obstacles, how the members communicated, suggested improvements, and their intention to continue team management of hypertension. The team relations were measured using the Physician-Pharmacist Collaboration Index (PPCI), assessing: Trustworthiness, Role Specification, and Relationship Initiation (1=strongly disagree -7=strongly agree) [11] [12] [13] . A second data source was BP management logs maintained by the pharmacists including: number of patients receiving team management, number of visits (initial and follow-up), number of BP readings at goal, and pharmacist actions (e.g., patient education, communication with provider). Only de-identified data were collected in the pharmacy logs.
The multi-case analyses began with combining team level information into a case report for each team. In addition to data about the team, the case report included a summary addressing three guide questions, which were used in case studies to help summarize the data [14] . Questions were: 1) How well did this team BP management work? 2) How was the BP management done for this team? and 3) What factors affected the success of this BP management team? In addition, the case reports were used in cross-case analyses based on overall case/team performance.
Results
Eleven provider-community pharmacist(s) teams participated throughout the state of Iowa (Table 1) . Of these teams, six (54.5%) of the pharmacies were part of a chain, while eight (72.7%) of the clinics were part of a larger health system. The teams encompassed a total of twelve pharmacists of which eight (66.7%) were female, while seven (53.8%) of the thirteen providers were female. The pharmacists' ages ranged from 26 to 64 with an average of 41.5, while the providers were slightly older ranging from 35 to 64 with an average of 48.6.
Each team was rated on overall performance, based on two criteria: 1) extent to which they established a system to support the team management approach and 2) number of patients who participated in their team BP management. Initial judgments, made by a single judge, were assessed and discussed by other members to reach a single rating. Four teams were categorized as Worked-Well (Cases A, B, C, D), five teams as Limited-Success (E, F, G, H, I), and two teams as No-Team-Approach (J, K).
The four Worked-Well teams were able to establish a system supporting the team management approach including: an effective process for identifying and recruiting patients, clear roles for team members, trusting relations between team members, and effective communication procedures. Having a system in place for the team management of BP, these four teams identified and recruited 6-18 patients who received 22-33 BP visits ( Table 2 ). Unlike some of the lesser performing teams, patient factors were not obstacles to their team management approach, and the practitioners committed time to team care.
The five teams with Limited-Success either did not fully establish a system to support the team approach (Cases E, F, G) or they only recruited a few patients despite having a functional team system (Cases H, I). The teams without supportive systems did not have clear roles for team members, or lacked effective communication methods. Thus, when difficulties came up at their practices, such as identifying patients or patient decline of the team approach, they only provided minimal team management of BP.
In contrast, two of the teams in this category appeared to have established functional systems to support their team management approach. However, few (<3 patients) received team management. Practitioner time (both provider and pharmacist) was a factor in both cases. In one case both team members had significant administrative responsibilities, which likely contributed to their time challenges.
Two cases (Cases J, K) were rated as No-Team-Approach because team management of BP was not provided. These practitioners had problems with some or all of the system components. In addition, no patients were recruited, though some initial efforts were made to identify patients. The members did not report good/trusting relations during the project, lacking the rapport needed to build a team. In the absence of the team support system, some patient resistance came up, and the practitioners were not able to overcome it. It is possible that these teams did not receive a sufficient team building intervention. One case did not have a face-toface team building session with the project leaders due to miscommunication. Rather, the project leaders met separately with them and sent communications to each practitioner, which limited the focused discussions. While the pharmacist did conduct several patient visits, no coordination with the provider occurred.
The practitioners of the other case met face-to-face, but later reported confusion about their roles and a need for better communication (e.g., forms). Both roles and communication were covered during their team building session and their plans were recorded. It is unclear why this team did not develop, though both practitioners stated patients were not interested in the team approach. As a solo practitioner with a low patient volume, the provider may have preferred handling care herself.
Discussion
Overall, the project was partially effective in fostering provider-pharmacist team management of BP in smaller communities. The four successful teams established a system to support the team approach and actively provided team management of BP to the most patients. Five teams achieved limited success, either establishing a system for the team approach, but only recruiting a few patients, or establishing a low-functioning system for their team approach. Finally, two cases did not establish a team approach at all, by not developing a sufficient team support system.
Objective 1
Eleven provider-pharmacist teams were recruited, though not all effectively provided team management of high BP. The teams that did not establish a functioning system were the first three teams participating in team building. It is possible the project leaders learned to lead more effective team building sessions, though a consistent outline was followed for all sessions. While follow-up emails were sent after the team building, no further face-to-face communication was mandatory. Teams were encouraged to meet 6-8 weeks after the team building session to discuss the status of the team approach, and to identify improvements if needed.
It is likely the team building program could be improved by providing more follow-up communication, which was intentionally limited to allow teams to operate on their own. Additional support could involve more communication after the initial team building session to help identify and resolve obstacles, to push progress in team care. Practitioners may not clearly recall their specific team roles, or might have problems with communications. Some follow-up team conference calls could boost members to more firmly establish a team system. Future work should incorporate team support such as conference calls or one-on-one interactions.
Objective 2
Objective 2 was to determine impact of the team approach on practitioner-reported consequences. Across the 11 cases, a total of 62 patients received BP visits with a pharmacist. This varied from a mean of 12.8 patients for the Worked-Well teams, 1.8 for the Limited-Success teams, and none for the No-Team-Care cases. In addition, the number of follow-up visits had a similar pattern, with averages of 13.8 for the Worked-Well teams, 5 for the Limited-Success and none for the No-Team-Care.
Some of the teams, especially the lowest performing ones, mentioned patient issues as obstacles. Previous research on patient willingness to utilize new pharmacist services has shown that if the patient expects to receive a valuable service, then he/she is more willing to try it [15] [16] . So, the manner in which the service was presented to the patients could have affected their interest. For example, if the pharmacist talked about better BP control or convenience for patients, they may have been more interested than if the pharmacist talked about how it would help the pharmacist or physician. How to approach patients was discussed during the team building sessions; however, specific talking points about team management were not provided. Future efforts should include some training and materials for practitioners, especially the pharmacists, to use when presenting the team care approach to patients.
A second consequence assessed was the impact on providerpharmacist relations. The practitioner relations were generally good across the teams, though the lowest ratings occurred with the No-Team-Care cases. Trusting professional relations are a necessary, but not sufficient, characteristic for successful teams. These practitioners generally had little opportunity for face-to-face communication; however relationships developed when practitioners were committed to the plan established during the team building session. The communications from the BP visits helped demonstrate the pharmacists' expertise, which has been identified as a determinant of trustworthiness [15] [16] .
For most of these participants, this team approach was something new for both partners. It appears that in most cases, especially those less successful, members were conservative in expanding the pharmacists' roles. Having the pharmacists conduct patient visits with a BP check was acceptable to most participants. However, fewer participants were comfortable with having the pharmacists recommend a change in drug therapy. It typically takes repeated communication for team members to fully develop their roles. For some of these teams, sporadic interactions between the providers and pharmacists limited their ability to develop a broader clinical role for the community pharmacists. Mechanisms for establishing new roles in teams such as these could be identified through future research. We enrolled one clinic that was affiliated with a larger organization. In this clinic there are 7 practitioners. The patient population consists of 8% Medicaid beneficiaries and 25% Medicare beneficiaries, wherein 20% of all clinic patients have hypertension. The physician team member was a male MD, age 52, who cares for about 150 patients per week.
INNOVATIONS in pharmacy

The pharmacy that paired with the clinic was a large chain, which owns 10 or more pharmacies in the state of Iowa. The pharmacy staff included 1 pharmacy technician and 1 pharmacist. The prescription volume averages 100 per week, all of which are dispensed by the team member. Of the prescriptions, 35% are for Medicaid beneficiaries and 50% are for Medicare beneficiaries. At this pharmacy 20% of the patients have hypertension. The pharmacist team member was a female, age 26, with a PharmD.
Baseline rating for trustworthiness for the physician was 6.33 and after the follow-up survey it ended at 6.83 while the pharmacist's was 5.33 and ended at 7. The baseline rating for role specification of the physician was 4.67 and after the follow-up survey it ended at 5.56 and for the pharmacist's was 4.89 and ended at 7. Baseline rating of relationship initiation for the physician was 4.67 and after the follow-up survey it ended at 6 while the pharmacist's was 5.66 and ended at 7. Overall the team relations were improved.
The Team planned the BP management as follows: Prescriber's Roles: Refer patients to pharmacist as needed, OK to have pharmacist do BP checks, Uses Mediterranean food diet pyramid; Pharmacist's Roles: Conduct BP visits with patients, Communicate with physician as needed, Give patients wallet car, Pharmacist will get Mediterranean diet from oldways.com; Patient Identification: Physician identifies patients with new HTN diagnosis; Communication Strategies: Faxes, Pharmacist can fax BP logs to prescriber, Eprescribe comment section-uses to notify, Pharmacist can communicated with nurse, Add info to pharmacist notes in E-prescribing; Patient Follow-up Schedule: Doctor will see patient every 2 weeks if new med or dose change, Then in 3-6 months if at goal, depending on other issues
The total number of BP visits was 7 (3 Initial and 4 Follow-up). The BP readings ranged from 110/79 to 128/97, with 4 of 7 at goal. At 7 visits the pharmacist conducted patient education, while at 1 visit the pharmacist made an adherence intervention. Summary Guide Question 1: How well did this team BP management work?
At baseline, both the pharmacist and physician rated each other about average in all three categories, but in the end both increased their ratings of the other in all three categories. The pharmacist provided 7 BP visits, with 3 of these being initial visits. For the initial BP readings, 2 of 3 were at goal, while 2 of 4 of the follow-up BP readings were at goal. During each BP visit the pharmacist would educate the patient on BP management as well as the uses of the Mediterranean diet. The pharmacist felt that the physician was very timely in following up with faxes and accepted all recommendations. Overall, this BP management team had limited success.
Guide Question 2: How was the BP management done for this team?
The pharmacist looked up the patients seen by the physician and started the project with those 3 patients in mind. The physician also sent over other patients when they were interested, believing that it may be more comfortable for a patient to take their BP at another location besides their office. After each BP check the pharmacist would fax the information to the physician's office and educate the patient on BP management as well as the uses of the Mediterranean diet.
Guide Question 3: What factors affected the success of this BP management team?
The pharmacy was new and therefore had few patients, 3 of which were seen by this physician. So recruiting patients was challenging for this team. Though there were few patients and most had their BP controlled. The pharmacist felt that good communication was established with the physician. Both agree that more patients and more time for the project would be beneficial in the future. The pharmacist also felt that more disease management conditions could be added.
